Jachiet, Vincent
Ricard, Laure
Hirsch, Pierre
Malard, Florent
Pascal, Laurent
Beyne-Rauzy, Odile
Peterlin, Pierre
Maria, Alexandre Thibault Jacques
Vey, Norbert
D’Aveni, Maud
Gourin, Marie-Pierre
Dimicoli-Salazar, Sophie
Banos, Anne
Wickenhauser, Stefan
Terriou, Louis
De Renzis, Benoit
Durot, Eric
Natarajan-Ame, Shanti
Vekhoff, Anne
Voillat, Laurent
Park, Sophie
Vinit, Julien
Dieval, Céline
Dellal, Azeddine
Grobost, Vincent
Willems, Lise
Rossignol, Julien
Solary, Eric
Kosmider, Olivier
Dulphy, Nicolas
Zhao, Lin Pierre
Adès, Lionel
Fenaux, Pierre
Fain, Olivier
Mohty, Mohamad
Gaugler, Béatrice
Mekinian, Arsène
,
Article History
Received: 10 June 2022
Accepted: 13 July 2022
First Online: 11 August 2022
Declarations
:
: AM is investigator of CELGENE, ROCHE, CHUGAI founded trials with APHP and Hopital 15–20 promotion; AM received several fees for congress travels and experts’ use from LFB, SANOFI, SHIRE, and CELGENE. The other authors declare no conflict of interest.
: All participants provided written informed consent. The study was approved by the local institutional review board (EudraCT 2016-000918-30, ANSM (Agence Nationale de Sécurité du Médicament) 160580A-11, registration date 26-AUG-2016) and in accordance with the Declaration of Helsinki.
: Not applicable.